Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820.

Published: 1st January 2007

Authors: Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A et al.

Conclusion

The addition of a year of oral chemotherapy to extended resection improved three year survival from 70.1 to 80.1 per cent (P=0.003) in this study that included 529 patients.



 

Pubmed Link

Your comments

0 Comments